EGF-related peptides in the pathophysiology of the mammary gland
- PMID: 10882300
- DOI: 10.1023/a:1026351730785
EGF-related peptides in the pathophysiology of the mammary gland
Abstract
Normal mammary gland development is the result of complex interactions between a number of hormones and growth factors. Normal and malignant human mammary epithelial cells are able to synthesize and to respond to various different, locally acting growth factors and growth inhibitors. Among these, the EGF-related peptides play an important role in regulating the proliferation and differentiation of human mammary epithelial cells. EGF4 and TGF4 are able to stimulate the lobulo-alveolar development of the mammary gland in vivo as well they are involved in the pathogenesis of human breast cancer. Experimental evidence suggests that estrogen-induced proliferation of breast carcinoma cells is mediated in part by EGF-related growth factors. It has also been demonstrated that activation of certain cellular protooncogenes such as c-Ha-ras in human mammary epithelial cells results in cellular transformation and in an increased production of several EGF-related growth factors such as TGFalpha and amphiregulin. Coexpression of both EGF-related peptides and their own receptors frequently occurs in human breast carcinomas and in human breast cancer cell lines, suggesting that an autocrine pathway of uncontrolled cell growth sustains neoplastic transformation.
Similar articles
-
Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia.J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):119-29. doi: 10.1023/a:1026347629876. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882298 Review.
-
The mammary gland.Baillieres Clin Endocrinol Metab. 1991 Dec;5(4):809-32. doi: 10.1016/s0950-351x(10)80016-3. Baillieres Clin Endocrinol Metab. 1991. PMID: 1755817 Review.
-
EGF and TGF alpha modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: possible role of the arachidonic acid pathway.J Cell Biochem. 1995 Mar;57(3):495-508. doi: 10.1002/jcb.240570315. J Cell Biochem. 1995. PMID: 7768984
-
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.Breast Cancer Res Treat. 1994 Jan;29(1):11-27. doi: 10.1007/BF00666178. Breast Cancer Res Treat. 1994. PMID: 7912564 Review.
-
Growth factors, apoptosis, and survival of mammary epithelial cells.J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):229-37. doi: 10.1023/a:1018789527533. J Mammary Gland Biol Neoplasia. 1999. PMID: 10426402 Review.
Cited by
-
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.Breast Cancer Res. 2005;7(2):R267-73. doi: 10.1186/bcr996. Epub 2005 Jan 26. Breast Cancer Res. 2005. PMID: 15743507 Free PMC article.
-
Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors.Cancer Cell Int. 2010 Sep 1;10:30. doi: 10.1186/1475-2867-10-30. Cancer Cell Int. 2010. PMID: 20809984 Free PMC article.
-
Impairment of ubiquitylation by mutation in Drosophila E1 promotes both cell-autonomous and non-cell-autonomous Ras-ERK activation in vivo.J Cell Sci. 2009 May 1;122(Pt 9):1461-70. doi: 10.1242/jcs.042267. Epub 2009 Apr 14. J Cell Sci. 2009. PMID: 19366732 Free PMC article.
-
Understanding and circumventing resistance to anticancer monoclonal antibodies.MAbs. 2009 May-Jun;1(3):222-9. doi: 10.4161/mabs.1.3.8292. Epub 2009 May 24. MAbs. 2009. PMID: 20065642 Free PMC article. Review.
-
The ErbB receptors as targets for breast cancer therapy.J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):337-51. doi: 10.1023/a:1018762216147. J Mammary Gland Biol Neoplasia. 1999. PMID: 10705918 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials